Molecular Templates Appoints Corazon Dating Sanders, Ph.D., to its Board of Directors by Seini Moimoi | Dec 19, 2019 | Portfolio News
Axonics® Granted Six U.S. Patents and Allowed Three Additional Patents Related to its Implantable Sacral Neuromodulation Technology by Seini Moimoi | Dec 19, 2019 | Portfolio News
Aptinyx to Present Preclinical Data Exhibiting Effects of NYX-783 in Models of PTSD and Alcohol Use Disorder at the American College of Neuropsychopharmacology’s Annual Meeting by Seini Moimoi | Dec 9, 2019 | Portfolio News
Axonics® Provides Survey Results from Physician Seminar Series Showcasing the Recently FDA Approved Axonics r-SNM® System by Seini Moimoi | Dec 9, 2019 | Portfolio News
Sierra Oncology Reports Decreased Transfusion Requirements for Patients Treated with Momelotinib Directly Compared to Ruxolitinib at ASH Annual Meeting by Seini Moimoi | Dec 7, 2019 | Portfolio News
